Bio Green Med Solution, Inc. (BGMS) Fair Value 2026

BGMS · Building Products & Equipment ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.9 /10

32 fundamental signals · 0 models active

Value Trap Risk

DANGER (61/100)

Quick Summary — As of 2026-08-28, Bio Green Med Solution, Inc. (BGMS) trades at $0.86. QOC: 4.9/10. Value Trap Risk: 61/100 (DANGER). 0/13 models active.

Key Facts

Ticker
BGMS
Price
$0.86
Quality Score
4.9/10
Value Trap Risk
61/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 61 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give BGMS?

0 Intrinsic Value Models vs. Current Price ($0.86)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Bio Green Med Solution, Inc. (BGMS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Bio Green Med Solution, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About BGMS?

0 of 13 models are currently active for BGMS. See which stocks rank higher →

How Does BGMS Rank in Building Products & Equipment?

Among 39 Building Products & Equipment stocks, BGMS ranks #34 by Quality of Company score. CirclFi's QOC score of 4.9/10 evaluates 32 fundamental signals. A score of 4.9 reflects mixed fundamentals.

As a industrial sector, Bio Green Med Solution, Inc. operates in a sector where aftermarket revenue mix is a critical driver of valuation. Investors evaluating BGMS should weigh these sector-specific dynamics alongside our model-derived fair values.

Is BGMS a Value Trap?

CirclFi's Value Trap algorithm assigns BGMS a score of 61/100 (DANGER). This is a high-risk signal. Deteriorating fundamentals suggest the discount may be justified. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Bio Green Med Solution, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Bio Green Med Solution, Inc.'s fundamental quality profile registers 4.9/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record. Investors should note the company's elevated value trap risk score, which suggests apparent undervaluation may not be what it seems.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BGMS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Bio Green Med Solution, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Building Products & Equipment Stocks Should You Also Analyze?

11 related Building Products & Equipment stocks with 13-model coverage

STAIScanTech AI Systems Inc.QOC 5.0MAIRMadison Air Solutions CorporationQOC 4.8AIRJAirJoule Technologies CorporationQOC 5.1AEHLAntelope Enterprise Holdings LimitedQOC 4.7SNTLSentinel Holdings Ltd.QOC 5.2EVOHEvoAir Holdings Inc.QOC 4.4AWIArmstrong World Industries, Inc.QOC 9.0JBIJanus International Group, Inc.QOC 7.9BLDRBuilders FirstSource, Inc.QOC 7.3TTTrane Technologies plcQOC 9.4LIILennox International Inc.QOC 9.4

Read investment analysis: STAI · MAIR · AIRJ · AEHL · SNTL · EVOH · AWI · JBI · BLDR · TT · LII

Which Other Stocks Have a Similar Quality Score to BGMS?

7 companies across all industries closest to BGMS’s Quality of Company score of 4.9/10.

AUSTAustin Gold Corp.QOC 4.9FBLGFibroBiologics, Inc.QOC 4.9PCTPureCycle Technologies, Inc.QOC 4.9NCLNorthann CorpQOC 4.9QVCGQVC Group Inc.QOC 4.9PIMFranklin Master Intermediate Income TrustQOC 4.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AUST · FBLG · PCT · NCL · QVCG · PIM · NVDA

What Else Do Investors Ask About Bio Green Med Solution, Inc.’s Valuation?

What is Bio Green Med Solution, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Bio Green Med Solution, Inc. (BGMS). The Quality of Company score is 4.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BGMS overvalued or undervalued right now?

At $0.86, 0 of 0 active models suggest BGMS may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Bio Green Med Solution, Inc.'s business model in Building Products & Equipment.

What does a Quality of Company score of 4.9 mean for BGMS?

Bio Green Med Solution, Inc.'s QOC of 4.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on BGMS?

CirclFi analyzes BGMS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is BGMS a value trap in 2026?

Bio Green Med Solution, Inc.'s Value Trap score is 61/100 (DANGER). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Bio Green Med Solution, Inc. (BGMS) a Quality of Company score of 4.9/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/BGMS/ · Methodology
Primary sources for this BGMS valuation
  • Financial statements: Bio Green Med Solution, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001130166) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for BGMS as of ; valuations recomputed .